AxoGen, Inc. (0HKD.L)
USD 15.78
(-0.88%)
USD 15.78
(-0.88%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -21.46 Million USD | 27.75% |
| 2022 | -29.7 Million USD | -16.88% |
| 2021 | -25.41 Million USD | -9.64% |
| 2020 | -23.18 Million USD | 26.19% |
| 2019 | -31.4 Million USD | -53.2% |
| 2018 | -20.5 Million USD | -157.82% |
| 2017 | -7.95 Million USD | 2.2% |
| 2016 | -8.12 Million USD | 12.27% |
| 2015 | -9.26 Million USD | 5.45% |
| 2014 | -9.8 Million USD | -2.17% |
| 2013 | -9.59 Million USD | -22.95% |
| 2012 | -7.8 Million USD | -11.96% |
| 2011 | -6.96 Million USD | -276.99% |
| 2010 | -1.84 Million USD | -111.59% |
| 2009 | 15.95 Million USD | 1609.83% |
| 2008 | -1.05 Million USD | -32.11% |
| 2007 | -799.92 Thousand USD | -101.3% |
| 2006 | -397.37 Thousand USD | -21.7% |
| 2005 | -326.52 Thousand USD | -162.05% |
| 2004 | -124.6 Thousand USD | 89.99% |
| 2003 | -1.24 Million USD | 50.03% |
| 2002 | -2.49 Million USD | 24.84% |
| 2001 | -3.31 Million USD | -14.71% |
| 2000 | -2.89 Million USD | -60.58% |
| 1999 | -1.8 Million USD | -350.0% |
| 1998 | -400 Thousand USD | -500.0% |
| 1997 | 100 Thousand USD | 116.67% |
| 1996 | -600 Thousand USD | -500.0% |
| 1995 | -100 Thousand USD | -112.5% |
| 1994 | 800 Thousand USD | 14.29% |
| 1993 | 700 Thousand USD | -41.67% |
| 1992 | 1.2 Million USD | 9.09% |
| 1991 | 1.1 Million USD | 83.33% |
| 1990 | 600 Thousand USD | -14.29% |
| 1989 | 700 Thousand USD | -30.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -4.56 Million USD | -42.77% |
| 2024 Q2 | -428 Thousand USD | 90.61% |
| 2023 Q4 | -3.19 Million USD | 20.65% |
| 2023 Q2 | -6.9 Million USD | 5.98% |
| 2023 Q3 | -4.02 Million USD | 41.68% |
| 2023 Q1 | -7.34 Million USD | -30.9% |
| 2023 FY | -21.46 Million USD | 27.75% |
| 2022 Q2 | -7.92 Million USD | 30.0% |
| 2022 Q3 | -4.85 Million USD | 38.73% |
| 2022 Q4 | -5.6 Million USD | -15.51% |
| 2022 Q1 | -11.32 Million USD | -111.47% |
| 2022 FY | -29.7 Million USD | -16.88% |
| 2021 Q3 | -6.68 Million USD | 6.5% |
| 2021 Q1 | -6.22 Million USD | -15.74% |
| 2021 FY | -25.41 Million USD | -9.64% |
| 2021 Q4 | -5.35 Million USD | 19.97% |
| 2021 Q2 | -7.15 Million USD | -15.02% |
| 2020 Q1 | -8.5 Million USD | -14.69% |
| 2020 FY | -23.18 Million USD | 26.19% |
| 2020 Q4 | -5.37 Million USD | -414.26% |
| 2020 Q3 | -1.04 Million USD | 87.34% |
| 2020 Q2 | -8.25 Million USD | 3.0% |
| 2019 Q1 | -10.2 Million USD | -74.44% |
| 2019 FY | -31.4 Million USD | -53.2% |
| 2019 Q3 | -6.11 Million USD | 20.33% |
| 2019 Q4 | -7.41 Million USD | -21.38% |
| 2019 Q2 | -7.67 Million USD | 24.81% |
| 2018 Q3 | -4.83 Million USD | -0.35% |
| 2018 Q4 | -5.84 Million USD | -20.98% |
| 2018 FY | -20.5 Million USD | -157.82% |
| 2018 Q2 | -4.81 Million USD | 3.49% |
| 2018 Q1 | -4.99 Million USD | -176.26% |
| 2017 Q1 | -3.2 Million USD | -17.68% |
| 2017 Q2 | -1.44 Million USD | 54.83% |
| 2017 Q3 | -1.49 Million USD | -3.65% |
| 2017 FY | -7.95 Million USD | 2.2% |
| 2017 Q4 | -1.8 Million USD | -20.59% |
| 2016 Q2 | -1.6 Million USD | 38.77% |
| 2016 Q1 | -2.62 Million USD | 1.1% |
| 2016 FY | -8.12 Million USD | 12.27% |
| 2016 Q3 | -1.18 Million USD | 26.42% |
| 2016 Q4 | -2.71 Million USD | -130.13% |
| 2015 FY | -9.26 Million USD | 5.45% |
| 2015 Q4 | -2.65 Million USD | -38.28% |
| 2015 Q1 | -2.54 Million USD | 6.1% |
| 2015 Q2 | -2.15 Million USD | 15.35% |
| 2015 Q3 | -1.91 Million USD | 10.93% |
| 2014 Q1 | -2.99 Million USD | -6.93% |
| 2014 FY | -9.8 Million USD | -2.17% |
| 2014 Q4 | -2.7 Million USD | -50.26% |
| 2014 Q3 | -1.8 Million USD | 21.54% |
| 2014 Q2 | -2.29 Million USD | 23.18% |
| 2013 Q4 | -2.79 Million USD | -22.85% |
| 2013 Q2 | -2.19 Million USD | 5.56% |
| 2013 Q1 | -2.32 Million USD | -4.15% |
| 2013 FY | -9.59 Million USD | -22.95% |
| 2013 Q3 | -2.27 Million USD | -3.77% |
| 2012 Q4 | -2.23 Million USD | -9.21% |
| 2012 FY | -7.8 Million USD | -11.96% |
| 2012 Q3 | -2.04 Million USD | -28.75% |
| 2012 Q2 | -1.58 Million USD | 18.25% |
| 2012 Q1 | -1.94 Million USD | 2.42% |
| 2011 Q1 | 1.48 Million USD | 385.17% |
| 2011 Q2 | 513.18 Thousand USD | -65.49% |
| 2011 Q3 | -2.62 Million USD | -611.79% |
| 2011 FY | -6.96 Million USD | -276.99% |
| 2011 Q4 | -1.98 Million USD | 24.27% |
| 2010 Q3 | -613.5 Thousand USD | -81.18% |
| 2010 Q4 | -521.45 Thousand USD | 15.0% |
| 2010 FY | -1.84 Million USD | -111.59% |
| 2010 Q1 | -374.94 Thousand USD | -102.33% |
| 2010 Q2 | -338.62 Thousand USD | 9.69% |
| 2009 Q4 | 16.08 Million USD | 12376.5% |
| 2009 FY | 15.95 Million USD | 1609.83% |
| 2009 Q3 | -131 Thousand USD | -194.37% |
| 2009 Q1 | -134.99 Thousand USD | -10.0% |
| 2009 Q2 | 138.82 Thousand USD | 202.84% |
| 2008 FY | -1.05 Million USD | -32.11% |
| 2008 Q1 | -166.88 Thousand USD | -458.55% |
| 2008 Q4 | -122.71 Thousand USD | 79.05% |
| 2008 Q3 | -585.84 Thousand USD | -223.06% |
| 2008 Q2 | -181.34 Thousand USD | -8.66% |
| 2007 FY | -799.92 Thousand USD | -101.3% |
| 2007 Q4 | -29.87 Thousand USD | 93.63% |
| 2007 Q3 | -469.28 Thousand USD | -173.54% |
| 2007 Q2 | -171.55 Thousand USD | -32.78% |
| 2007 Q1 | -129.2 Thousand USD | 27.34% |
| 2006 Q3 | -61.92 Thousand USD | 41.61% |
| 2006 Q2 | -106.06 Thousand USD | -105.65% |
| 2006 Q1 | -51.57 Thousand USD | -137.49% |
| 2006 FY | -397.37 Thousand USD | -21.7% |
| 2006 Q4 | -177.81 Thousand USD | -187.15% |
| 2005 FY | -326.52 Thousand USD | -162.05% |
| 2005 Q3 | -19.13 Thousand USD | 71.29% |
| 2005 Q2 | -66.65 Thousand USD | 82.38% |
| 2005 Q1 | -378.31 Thousand USD | -309.35% |
| 2005 Q4 | 137.57 Thousand USD | 819.05% |
| 2004 Q4 | 180.7 Thousand USD | 228.04% |
| 2004 Q1 | 79.67 Thousand USD | 141.84% |
| 2004 Q2 | 1505.00 USD | -98.11% |
| 2004 FY | -124.6 Thousand USD | 89.99% |
| 2004 Q3 | -141.13 Thousand USD | -9477.87% |
| 2003 Q1 | -290.67 Thousand USD | 55.8% |
| 2003 Q2 | -427.27 Thousand USD | -46.99% |
| 2003 Q4 | -190.44 Thousand USD | 43.45% |
| 2003 FY | -1.24 Million USD | 50.03% |
| 2003 Q3 | -336.77 Thousand USD | 21.18% |
| 2002 Q1 | -768.26 Thousand USD | 0.0% |
| 2002 Q4 | -657.69 Thousand USD | -95.79% |
| 2002 Q3 | -335.92 Thousand USD | 53.98% |
| 2002 Q2 | -730 Thousand USD | 4.98% |
| 2002 FY | -2.49 Million USD | 24.84% |
| 2001 FY | -3.31 Million USD | -14.71% |
| 2001 Q3 | -1.19 Million USD | 20.98% |
| 2001 Q2 | -1.51 Million USD | -151.22% |
| 2001 Q1 | -601.44 Thousand USD | 6.07% |
| 2000 Q2 | -829 Thousand USD | -30.09% |
| 2000 FY | -2.89 Million USD | -60.58% |
| 2000 Q1 | -637.25 Thousand USD | 20.34% |
| 2000 Q3 | -562.87 Thousand USD | 32.1% |
| 2000 Q4 | -640.32 Thousand USD | -13.76% |
| 1999 Q1 | -300 Thousand USD | 57.14% |
| 1999 FY | -1.8 Million USD | -350.0% |
| 1999 Q4 | -800 Thousand USD | -14.29% |
| 1999 Q3 | -700 Thousand USD | -40.0% |
| 1999 Q2 | -500 Thousand USD | -66.67% |
| 1998 Q1 | -300 Thousand USD | -200.0% |
| 1998 Q3 | -200 Thousand USD | 0.0% |
| 1998 Q4 | -700 Thousand USD | -250.0% |
| 1998 FY | -400 Thousand USD | -500.0% |
| 1998 Q2 | -200 Thousand USD | 33.33% |
| 1997 Q2 | 200 Thousand USD | -87.5% |
| 1997 Q4 | -100 Thousand USD | -150.0% |
| 1997 FY | 100 Thousand USD | 116.67% |
| 1997 Q1 | 1.6 Million USD | 900.0% |
| 1997 Q3 | 200 Thousand USD | 0.0% |
| 1996 Q4 | -200 Thousand USD | 0.0% |
| 1996 Q2 | - USD | -100.0% |
| 1996 FY | -600 Thousand USD | -500.0% |
| 1996 Q1 | 200 Thousand USD | 128.57% |
| 1996 Q3 | - USD | 0.0% |
| 1995 Q2 | -400 Thousand USD | -233.33% |
| 1995 Q4 | -700 Thousand USD | 0.0% |
| 1995 FY | -100 Thousand USD | -112.5% |
| 1995 Q3 | - USD | 100.0% |
| 1995 Q1 | 300 Thousand USD | 0.0% |
| 1994 Q4 | - USD | 0.0% |
| 1994 FY | 800 Thousand USD | 14.29% |
| 1994 Q1 | 100 Thousand USD | -50.0% |
| 1994 Q2 | - USD | -100.0% |
| 1994 Q3 | - USD | 0.0% |
| 1993 Q2 | 200 Thousand USD | 0.0% |
| 1993 Q1 | 200 Thousand USD | 0.0% |
| 1993 FY | 700 Thousand USD | -41.67% |
| 1993 Q4 | 200 Thousand USD | -60.0% |
| 1993 Q3 | 500 Thousand USD | 150.0% |
| 1992 Q1 | 300 Thousand USD | 0.0% |
| 1992 Q2 | 300 Thousand USD | 0.0% |
| 1992 Q3 | 300 Thousand USD | 0.0% |
| 1992 Q4 | - USD | -100.0% |
| 1992 FY | 1.2 Million USD | 9.09% |
| 1991 Q1 | 200 Thousand USD | 0.0% |
| 1991 Q4 | 300 Thousand USD | 0.0% |
| 1991 Q3 | 300 Thousand USD | 0.0% |
| 1991 FY | 1.1 Million USD | 83.33% |
| 1991 Q2 | 300 Thousand USD | 50.0% |
| 1990 FY | 600 Thousand USD | -14.29% |
| 1990 Q3 | 300 Thousand USD | 113.64% |
| 1990 Q4 | 200 Thousand USD | -33.33% |
| 1990 Q1 | 1.4 Million USD | 16.67% |
| 1990 Q2 | -2.2 Million USD | -257.14% |
| 1989 Q1 | 1.6 Million USD | -5.88% |
| 1989 Q4 | 1.2 Million USD | 500.0% |
| 1989 FY | 700 Thousand USD | -30.0% |
| 1989 Q3 | 200 Thousand USD | 104.88% |
| 1989 Q2 | -4.1 Million USD | -356.25% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Phreesia, Inc. | -131.77 Million USD | 83.713% |
| Accuray Incorporated | 504 Thousand USD | 4358.333% |
| Align Technology, Inc. | 643.33 Million USD | 103.336% |
| Elevance Health Inc. | 133.96 Billion USD | 100.016% |
| Boston Scientific Corporation | 2.34 Billion USD | 100.916% |
| CVS Health Corporation | 13.74 Billion USD | 100.156% |
| Cardinal Health, Inc. | 1.24 Billion USD | 101.727% |
| Centene Corporation | 2.93 Billion USD | 100.732% |
| DaVita Inc. | 1.6 Billion USD | 101.339% |
| HCA Healthcare, Inc. | 9.62 Billion USD | 100.223% |
| Hologic, Inc. | 970.2 Million USD | 102.212% |
| Humana Inc. | 4.01 Billion USD | 100.535% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | 101.956% |
| Laboratory Corporation of America Holdings | 725.6 Million USD | 102.958% |
| Masimo Corporation | 136.5 Million USD | 115.723% |
| McKesson Corporation | 3.9 Billion USD | 100.549% |
| Patterson Companies, Inc. | 252.92 Million USD | 108.486% |
| Quest Diagnostics Incorporated | 1.26 Billion USD | 101.701% |
| ResMed Inc. | 1.31 Billion USD | 101.626% |
| Henry Schein, Inc. | 615 Million USD | 103.49% |
| Teladoc Health, Inc. | -248.55 Million USD | 91.365% |
| Universal Health Services, Inc. | 1.17 Billion USD | 101.826% |
| Veeva Systems Inc. | 429.33 Million USD | 104.999% |
| Baxter International Inc. | 390 Million USD | 105.503% |
| Becton, Dickinson and Company | 2.11 Billion USD | 101.017% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 101.215% |
| Danaher Corporation | 5.38 Billion USD | 100.399% |
| Stryker Corporation | 3.88 Billion USD | 100.552% |
| Medtronic plc | 5.14 Billion USD | 100.417% |